Bruker Daltonics presents new innovative mass spectrometry-based life sciences instruments and solutions, like ETD, microorganism ID, and MALDI molecular imaging, at Pittcon scientific conference.
Posts Tagged ‘Mass Spectrometry’
Bruker Daltonics Mass Spectrometers Live at Pittcon
Wednesday, September 1st, 2010Mass Spectrometry for Microbial Proteomics
Sunday, August 29th, 2010
Product Description
New advances in proteomics, driven largely by developments in mass spectrometry, continue to reveal the complexity and diversity of pathogenic mechanisms among microbes that underpin infectious diseases. Therefore a new era in medical microbiology is demanding a rapid transition from current procedures to high throughput analytical systems for the diagnosis of microbial pathogens.
This book covers the broad microbiological applications of proteomics and… More >>
Mass Spectrometry for Microbial Proteomics
Industrial Proteomics: Applications for Biotechnology and Pharmaceuticals
Friday, August 27th, 2010
Product Description
This book covers both basic elements and the state-of-the-art in applications of proteomics. The first section gives an introduction to the field, from differential approaches to functional proteomics, including yeast two-hybrid, mass spectrometry, mapping of post-translational modifications, and NMR spectroscopy. The second section offers a complete picture of industry studies in proteomics for human health and biotechnology applications. The final section addresse… More >>
Industrial Proteomics: Applications for Biotechnology and Pharmaceuticals
Interview with an EMSL researcher: Robby Robinson
Saturday, July 17th, 2010
Read the transcript www.emsl.pnl.gov Robby Robinson discusses his research to derive better ways to analyze intact proteins using mass spectrometry, focusing on his work to develop an integrated, top-down/bottom-up, proteomics strategy, which he will present at the 57th ASMS Conference on Mass Spectrometry. Such studies not only improve researchers’ fundamental understanding, but may also help them find new ways to apply this understanding to help discover cures for diseases, improve biological remediation methods, and improve methods for applying biological sources to energy applications.
Protein Arrays, Biochips, and Proteomics
Monday, May 31st, 2010
Product Description
From disease marker identification to accelerated drug development, this reference offers a detailed overview of current and emerging trends in the field of proteomics—focusing on innovations in protein microarrays and biochips, mass spectrometry, high-throughput protein expression, protein–protein interactions, structural proteomics, and the proteomic marketplace for comprehensive understanding of proteomic research in the past, present, and future…. More >>
Protein Arrays, Biochips, and Proteomics
Proteomic depletion, antitrypsin: PMAP
Monday, May 24th, 2010www.proteolysis.org A1AT Alpha-1-antitrypsin. A1AT is inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form inhibits insulin-induced NO synthesis in platelets, decreases coagulation time and has proteolytic activity against insulin and plasmin. Proteomics is the large-scale study of proteins, particularly their structures and functions. The term “proteomics” was coined to make an analogy with genomics, the study of the genes. An interesting use of proteomics is using specific protein biomarkers to diagnose disease. A number of techniques allow to test for proteins produced during a particular disease, which helps to diagnose the disease quickly. Techniques include western blot, immunohistochemical staining, enzyme linked immunosorbent assay (ELISA) or mass spectrometry. Proteins of interest to biological researchers are usually part of a very complex mixture of other proteins and molecules that co-exist in the biological medium. This presents two significant problems. First, the two ionization techniques used for large molecules only work well when the mixture contains roughly equal amounts of constituents, while in biological samples, different proteins tend to be present in widely differing amounts. If such a mixture is ionized using electrospray or MALDI, the more abundant species have a tendency to “drown” or suppress …
Computational Methods for Mass Spectrometry Proteomics
Monday, April 26th, 2010
Product Description
Proteomics is the study of the subsets of proteins present in different parts of an organism and how they change with time and varying conditions. Mass spectrometry is the leading technology used in proteomics, and the field relies heavily on bioinformatics to process and analyze the acquired data. Since recent years have seen tremendous developments in instrumentation and proteomics-related bioinformatics, there is clearly a need for a solid introduction to the… More >>
Computational Methods for Mass Spectrometry Proteomics
I want to ask for some correction for English expression.?
Monday, April 12th, 2010Below is some part of my letter that is very important to me. Please give me some correction, if there is some awkward expressions. Thank you!
I am very interested in applying various technologies for biomedical study. I found that your research group is studying new diagnosis and therapeutic methods using various technologies such as proteomics, nanotechnology, molecular engineering and so on.
I think that your research field is what I am very interested in. Moreover, I have strong professional background for most of the technologies that you are using.
I am very familiar with most of biological study (phage-display, cell culture, gene cloning, protein purification, animal study etc.), proteomics (imaging mass spectrometry, LC-MS, MALDI-TOF etc.), DNA chip (diagnosis system development), and nanotechnology (gold nanoparticle, Raman spectroscopy, AFM).
The Proteomics Protocols Handbook
Monday, April 12th, 2010
Product Description
Hands-on researchers describe in step-by-step detail 73 proven laboratory methods and bioinformatics tools essential for analysis of the proteome. These cutting-edge techniques address such important tasks as sample preparation, 2D-PAGE, gel staining, mass spectrometry, and post-translational modification. There are also readily reproducible methods for protein expression profiling, identifying protein-protein interactions, and protein chip technology, as well as a … More >>
The Proteomics Protocols Handbook
Brand Principles Introduces Latest Market Research Report on Biomarkers
Saturday, April 3rd, 2010
BrandPrinciples.com a provider of latest market research reports specific to biotechnology industry announced the release of the latest market research report on Biomarkers. BrandPrinciples.com has been working on various market research reports pertaining to biotechnology which is there expertise and thus, concentrate only on this industry which is growing at a high speed. These unique research reports are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools.
This market research report on Biomarkers focuses on the different types of biomarkers and their impact on various disease areas such as oncology, neurology, cardiology and other areas including metabolomic turmoil, arthritis, gynecology, oxidative stress, liver disease, pulmonary disease and aging. The market report provides global market analysis for biomarkers by prominent biomarker discovery technologies including imaging, genomics, proteomics, metabolomics, bioinformatics and other technologies comprising fluorescent indicators, lab-on-chip, nuclear magnetic resonance, mass spectrometry / liquid chromatography and nanobiotechnology. Includes estimates and projections for the total global biomarkers market. Projections and estimates figure for geographic regions including United States, Europe, Japan, Asia-Pacific, Canada and rest of the world. A total of 402 companies are covered that are engaged in biomarkers R&D, discovery, testing, and supply of products and services.
Biomarkers discovery is fast gaining importance, especially in the field of medical research. Latest innovations in the area of transcriptomics, proteomics and metabolomics are driving the trend. Global biomarkers market is projected to reach about US$15 billion by 2010, with the United States retaining its dominance. Asia Pacific is the most vibrant region while Europe has some of the leading biomarkers companies. Cardiology is projected to be the fastest growing therapeutic area of biomarkers during the analysis period 2005-2010 with a CAGR of 22.3% followed by Neurology and Oncology. Bioinformatics is projected to be the fastest growing discovery technology for biomarkers for the analysis period 2005-2010 with a CAGR of 22.8% followed by Genomics and Metabolomics.
The latest trends and advancements in biotechnology have offered enormous expansion of genomics, proteomics and metabolomics fields by enabling cost effective DNA sequencing, mass spectroscopic antibody analyzing and evaluation of metabolic patterns of health by using NMR techniques. The introduction of these techniques to the field of biotechnology has led to the generation of incredible quantity of innovative biological and pharmaceutical information. The advancements in the field of information technology have enabled storing and retrieving of large quantities of data with minimal expenditure. The entry of mathematical applications into the field of biomarkers has helped in devising numerous mathematical and statistical equations to evaluate the stored medical and pharmaceutical data to provide error free biomarker development.
Click here for a free sample report on Biomarkers.
